109 related articles for article (PubMed ID: 6668505)
1. Breast cancer estrogen and progesterone receptor values: their distribution, degree of concordance, and relation to number of positive axillary nodes.
Fisher B; Wickerham DL; Brown A; Redmond CK
J Clin Oncol; 1983 Jun; 1(6):349-58. PubMed ID: 6668505
[TBL] [Abstract][Full Text] [Related]
2. Influence of tumor estrogen and progesterone receptor levels on the response to tamoxifen and chemotherapy in primary breast cancer.
Fisher B; Redmond C; Brown A; Wickerham DL; Wolmark N; Allegra J; Escher G; Lippman M; Savlov E; Wittliff J
J Clin Oncol; 1983 Apr; 1(4):227-41. PubMed ID: 6366135
[TBL] [Abstract][Full Text] [Related]
3. Relation of estrogen and/or progesterone receptor content of breast cancer to patient outcome following adjuvant chemotherapy.
Fisher B; Redmond CK; Wickerham DL; Rockette HE; Brown A; Allegra J; Bowman D; Plotkin D; Wolter J
Breast Cancer Res Treat; 1983; 3(4):355-64. PubMed ID: 6365208
[TBL] [Abstract][Full Text] [Related]
4. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.
Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC
Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788
[TBL] [Abstract][Full Text] [Related]
5. Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive.
Van Calster B; Vanden Bempt I; Drijkoningen M; Pochet N; Cheng J; Van Huffel S; Hendrickx W; Decock J; Huang HJ; Leunen K; Amant F; Berteloot P; Paridaens R; Wildiers H; Van Limbergen E; Weltens C; Timmerman D; Van Gorp T; Smeets A; Van den Bogaert W; Vergote I; Christiaens MR; Neven P
Breast Cancer Res Treat; 2009 Jan; 113(1):181-7. PubMed ID: 18264760
[TBL] [Abstract][Full Text] [Related]
6. Determination of threshold values for determining the size of the fraction of steroid hormone receptor-positive tumor cells in paraffin-embedded breast carcinomas.
Leers MP; Hoop JG; van Beers M; van Rodijnen N; Pannebakker M; Nap M
Cytometry B Clin Cytom; 2005 Mar; 64(1):43-52. PubMed ID: 15668953
[TBL] [Abstract][Full Text] [Related]
7. Distribution of estrogen and progesterone receptors on primary tumor and lymph nodes in individual patients with breast cancer.
Klinga K; Kaufmann M; Runnebaum B; Kubli F
Oncology; 1982; 39(6):337-9. PubMed ID: 7133597
[TBL] [Abstract][Full Text] [Related]
8. [Immunohistochemical investigation of estrogen and progesterone receptors in breast tumors].
Ellinidi VN; Anikseeva NV; Goncharova OA; Krasnozhon DA; Fedorov KA
Vopr Onkol; 2004; 50(2):234-6. PubMed ID: 15176229
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical detection of estrogen and progesterone receptors in primary breast cancer.
Chariyalertsak S; Chariyalertsak S; Ruangvejvorachi P
Asian Pac J Allergy Immunol; 1998 Dec; 16(4):161-6. PubMed ID: 10219897
[TBL] [Abstract][Full Text] [Related]
10. Regional lymph node reactions related to hormone receptor status in female breast carcinoma.
Kosma VM; Syrjänen KJ
Arch Geschwulstforsch; 1985; 55(2):123-30. PubMed ID: 4004508
[TBL] [Abstract][Full Text] [Related]
11. The effect of tumor size and axillary lymph node metastasis on estrogen and progesterone receptors in primary breast cancer.
Alghanem AA; Hussain S
J Surg Oncol; 1986 Mar; 31(3):218-21. PubMed ID: 3724175
[TBL] [Abstract][Full Text] [Related]
12. Elastosis in human breast cancer. Correlation with sex steroid receptors and comparison with clinical outcome.
Glaubitz LC; Bowen JH; Cox EB; McCarty KS
Arch Pathol Lab Med; 1984 Jan; 108(1):27-30. PubMed ID: 6546333
[TBL] [Abstract][Full Text] [Related]
13. [Loss of hormonal receptors expression from primary breast carcinoma to axillary lymph node metastases].
Cianga C; Cianga P; Cozma L; Diaconu C; Carasevici E
Rev Med Chir Soc Med Nat Iasi; 2003; 107(3):540-4. PubMed ID: 14756058
[TBL] [Abstract][Full Text] [Related]
14. [Estrogen and progesterone receptors of primary breast carcinoma and their axillary lymph node metastases--immunohistochemical investigations of routine formalin-fixed paraffin-embedded tissue].
Schulze MH; Buchmann J
Zentralbl Gynakol; 2000; 122(2):92-5. PubMed ID: 10721188
[TBL] [Abstract][Full Text] [Related]
15. Estrogen receptors and the pattern of relapse in breast cancer.
Qazi R; Chuang JL; Drobyski W
Arch Intern Med; 1984 Dec; 144(12):2365-7. PubMed ID: 6508445
[TBL] [Abstract][Full Text] [Related]
16. Quantitative progesterone receptor expression and efficacy of anti-estrogen therapy in breast cancer.
Luoh SW; Ramsey B; Park B; Keenan E
Breast J; 2014; 20(1):46-52. PubMed ID: 24261828
[TBL] [Abstract][Full Text] [Related]
17. Relationship between progesterone receptor, axillary node status and productive fibrosis in ductal infiltrating carcinoma of the breast.
Giani C; Campani D; De Negri F; Capotorti E; Savarese MR; Benigni G; Incensati RM; Breccia M; Miccoli P; Evangelista G
Appl Pathol; 1989; 7(4):225-32. PubMed ID: 2553078
[TBL] [Abstract][Full Text] [Related]
18. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
[TBL] [Abstract][Full Text] [Related]
19. Comparison of estrogen receptors, progesterone receptors and HER-2/neu expression between primary and metastatic breast carcinoma.
Azam M; Qureshi A; Mansoor S
J Pak Med Assoc; 2009 Nov; 59(11):736-40. PubMed ID: 20361669
[TBL] [Abstract][Full Text] [Related]
20. Biochemically estrogen receptor-negative, progesterone receptor-positive breast carcinoma. Immunocytochemical hormone receptors and prognostic factors.
Keshgegian AA
Arch Pathol Lab Med; 1994 Mar; 118(3):240-4. PubMed ID: 8135626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
